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We have known for decades that environ-
mentally derived phytoestrogens and myco-
toxins profoundly affect reproductive
function. These substances, which most
often inﬂuence estrogen receptor (ER)-regu-
lated pathways, stimulate cellular differentia-
tion and proliferation of the mammary
gland (1) and uterine growth and DNA syn-
thesis in rodents (2). Consequently, it is not
surprising that consumption of soy-supple-
mented diets is associated with the low-level
stimulation of vaginal corniﬁcation in post-
menopausal women (3). On this basis, some
investigators have suggested that phytoestro-
gens with impeded estrogenic activity may
actually reduce the incidence of breast and
prostate cancer in humans by competitively
blocking the effects of more active physio-
logic estrogens such as estradiol (4,5).
Although this hypothesis appears logical on
the surface, it is well documented that sus-
tained exposure to impeded estrogens
(estriol) or antiestrogens (tamoxifen) with
mild estrogenic activity causes mammary
cancer in experimental animals (6) and
endometrial cancer in women (7). Thus,
“impeded” estrogenic agents may be carcino-
genic when exposure is sustained, and their
impact on human health and development
may be substantially underestimated.
Consequently, environmentally derived
endocrine disruptors with mitogenic activity
may represent a signiﬁcant health problem if
exposure is chronic. 
The studies described in this article
concern a mitogenic agent isolated from
ground corncob animal bedding (corn mito-
gen; CM), from commercially available fresh
corn (kernels or cob), or from corn tortillas
which blocks male and female reproductive
behavior and also causes persistent metestrus
in adult female rats. CM does not appear to
be a classical phytoestrogen (8) or mycotoxin
such as zearalenone (9,10) because it does not
bind to ER and is able to stimulate prolifera-
tion of ER-positive or ER-negative human
breast cancer cells. Highly puriﬁed prepara-
tions of CM also do not compete for
[3H]estradiol binding to nuclear type II sites
in rat uterine preparations, as do other
bioﬂavonoids or related metabolites (11,12),
further suggesting that the mitogenic activity
of CM is mediated through nonestrogen-reg-
ulated pathways. CM also stimulates the
growth and proliferation of PC-3 human
prostatic cancer cells in vitro. Subcutaneous
PC-3 cell xenografts grow more rapidly in
athymic nude mice housed on ground corn-
cob bedding than in mice housed on pure
cellulose. Therefore, exposure to corncob
bedding materials or corn food products may
influence experimental results in studies
involving male and female reproductive func-
tion and/or breast and prostatic cancer cell
proliferation. Because corn represents a major
human food source, sustained exposure to
CM could affect human health, develop-
ment, and reproductive function as well. 
Methods and Materials
Animals and treatment. The adult male and
female Sprague-Dawley rats used for these
studies were purchased from Harlan
(Houston, TX). For some experiments, adult
female rats were ovariectomized under meto-
fane anesthesia and rested for 14 days before
the study. Animals were housed in sus-
pended wire cages, with hardwood chips
(Sani-chips; P.J. Murphy Forest Product
Corporation, Montville, NJ) or ground corn-
cob (Bedocob; Green Products Company,
Conrad, IA) bedding as described for the
individual studies below. Standard lighting
conditions (12-hr light–dark cycle, lights on
at 0600 hr) were used unless speciﬁed other-
wise in the text and ﬁgure legends. Food and
water were provided ad libitum. We used
BALb/c nu/nu athymic nude mice (Harlan),
to assess the effects of cellulose or corncob
bedding material on the growth of PC-3
human prostatic cancer cell xenografts.
These animals were housed in cages contain-
ing the autoclaved purified cellulose or
ground corncob bedding in the pathogen-
free barrier facility at Baylor College of
Medicine. Autoclaving did not modify the
CM activity in the corncob bedding material
for studies with nude mice. Mice were
housed under constant lighting conditions,
and sterilized food and water were provided
ad libitium. 
All animals were housed in Association
for Assessment and Accreditation of
Laboratory Animal Care–approved animal
facilities and received the highest standard of
humane care in accordance with the NIH
Guide for the Care and Use of Laboratory
Animals (13). Ovariectomies were performed
under metofane ansethesia using aseptic
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Housing adult rats on ground corncob bedding impedes male and female mating behavior and
causes acyclicity in females. The suppressive effects on ovarian cyclicity are mimicked by a mito-
genic agent puriﬁed from the ground corncob bedding material (corn mitogen; CM), which stim-
ulates the proliferation of estrogen receptor (ER)-positive (MCF-7 cells) and ER-negative
(MDA-MD-231 cells) breast cancer cells. Puriﬁed CM does not compete for [3H]estradiol bind-
ing to ER or nuclear type II sites, and its effects on MCF-7 breast cancer cell proliferation are not
blocked by the antiestrogen ICI-182,780. These results suggest that the active component is
unlikely to be a phytoestrogen, bioflavonoid, mycotoxin, or other known endocrine-disrupting
agent that modiﬁes cell growth via ER or type II [3H]estradiol binding sites. CM also stimulates
the proliferation of PC-3 human prostatic cancer cells in vitro, and the growth rate of PC-3 cell
xenografts is accelerated in nude male mice housed on ground corncob as opposed to pure cellu-
lose bedding. Consequently, this endocrine-disrupting agent in ground corncob bedding may
inﬂuence behavioral and physiologic reproductive response proﬁles and malignant cell prolifera-
tion in experimental animals. Fresh corn (kernels and cob) or corn tortillas also contain CM, indi-
cating that human exposure is likely; consequently, CM and/or related mitogens in corn products
may inﬂuence human health and development. Key words: breast cancer, corncob bedding, corn
mitogen, endocrine disruptor, estrogen receptor. Environ Health Perspect 110:169–177 (2002).
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Guide for the Care and Use of Laboratory
Animals as approved by the institutional
Committee on Animal Care and Use. In
some studies, animals were anesthetized with
metofane or a combination of ketamine, ace-
promazine, and xylazine and killed by cervi-
cal dislocation in accordance with the
aforementioned protocols.
Effects of housing conditions on
uterotropic response. Intact or ovariec-
tomized 60-day-old female rats (8–10 per
group) were housed for 14 days in wire
cages, on hardwood chips, or on ground
corncob bedding. At the termination of the
study, the animals were killed and uteri were
removed, stripped of extraneous tissue,
rinsed in chilled saline, blotted, and
weighed. We determined uterine wet weight
or DNA content as previously described
(14). Data were expressed as the mean ± SE
for each experimental group and analyzed
statistically with Instat (GraphPad Software,
San Diego, CA), using analysis of variance
(ANOVA) and a suitable multiple range test
on the treatment means. 
Effects of housing conditions on estrous
cycles in female rats. We housed 60-day-old
female rats in wire cages and collected daily
vaginal smears for 2–3 weeks to establish a
baseline index of cyclicity for each female.
Smears were stained with Giemsa and scored
for proestrus, estrus, metestrus, or diestrus
according to classical vaginal smearing tech-
nique (15). Data were expressed as the per-
centage of animals displaying normal estrous
cycles. The daily pattern of cyclicity was
established for each female during this 2- to
3-week period. After these preliminary stud-
ies, groups of these animals (10 per treat-
ment group) were housed in wire cages or on
corncob bedding for either 2 or 5 weeks.
Daily vaginal smears were taken during this
period, and estrous cycles were recorded. In
addition, a second group of 10 rats were
housed in wire cages for 14 days, moved to
corncob bedding for 14 days, and returned
to wire cages for 14 days. Daily vaginal
smears were collected throughout this 52-
day period, and bedding effects on the num-
bers of animals displaying normal 4- to
5-day estrous cycles were determined. 
In some studies, we assessed the effects of
orally administered CM extracts on estrous
cycles in adult female Sprague-Dawley rats
housed in wire cages. Daily vaginal smears
were taken for 6 weeks to establish that all
animals displayed normal 4- to 5-day cycles
before treatment. During week 7, the ani-
mals were segregated into treatment groups
(10 rats/group). The groups were given 2%
Tween-80–tap water vehicle (controls), a
low dose (0.2 mL/400 mL), or a high dose
(2.0 mL/400 mL) of the puriﬁed CM extract
[80% methanol Spice (Rainin, Woburn,
MA) cartridge eluate reconstituted as
described below] dissolved in this vehicle.
Vaginal smears were collected daily through-
out the 2- to 3-week treatment period. The
ovarian cycles of the vehicle controls did not
differ from those of animals maintained on
tap water (data not shown), and thus the
vehicle had no significant effect on the
estrous cycles of control animals.
Assessment of reproductive behavior in
male rats. Intact Harlan-Sprague-Dawley
male rats (10 per group) were housed in wire
cages, and their sexual performance in the
presence of sexually receptive females was
monitored during the dark phase of the
reversed light cycle. Ovariectomized-steroid
hormone-primed females of the same strain
were used as stimulus animals. These females
were brought into behavioral estrus by a sub-
cutaneous (sc) priming injection of 2 µg of
estradiol benzoate (EB) in sesame oil 48 hr
before receiving 100 µg of progesterone (sc).
We evaluated male sexual behavior by examin-
ing the number of mounts, intromissions,
ejaculations, ejaculation latencies (in seconds)
and grooming frequencies in a 30-min test
period with each sexually receptive female as
per established procedures (16). Sexual behav-
ior in the presence of sexually receptive (estro-
gen and progesterone primed) ovariectomized
rats housed in wire cages was also evaluated for
adult male proven breeders separately housed
on wood chips (Sani-Chips) or ground corn-
cob bedding for 7–10 days before exposure to
the females. The numbers of mounts, intro-
missions, ejaculations, ejaculation latencies in
seconds, or grooming frequencies observed
during a 30-min test period with each sexually
receptive female was scored.
Assessment of mating behavior (lordosis)
in female rats. We also evaluated the effect
of CM on the mating behavior of female rats
to determine whether this mitogenic agent
altered their receptive responses to males
(lordosis). For these studies, ovariectomized
rats (10 per group) were housed in hanging
metal cages (controls) or on ground corncob
bedding (treated animals) and maintained
on reverse light–dark cycles with lights off at
1200 hr and on at 2400 hr. These females
were primed with physiologic doses of estra-
diol benzoate (2 µg) followed by proges-
terone (100 µg) 48 hr later. The animals in
both groups were tested for lordosis response
in the presence of male rats during the dark
phase of the cycle, following published pro-
tocols (17,18). Lordosis is characterized by
classical back-arching reflex by the female
upon mounting by the male for a total of 10
mounts. This was scored and represented as
lordosis quotient (LQ = no. of lordoses/no.
of mounts × 100) and determined for the
animals housed on wire or corncob bedding. 
Isolation of CM activity from corncob
bedding or fresh corn. The methodology for
the isolation and purification of CM was
developed in our laboratory during the
course of this investigation. Methanol and
ethyl acetate were high-performance liquid
chromatography (HPLC) grade, and 100%
ethanol was glass redistilled before use.
Approximately 200 g of ground corncob
bedding (or corn kernels or cob from one ear
of corn) were extracted at 70°C for 2 hr in
600 mL of HPLC-grade methanol. The
extract was filtered through two layers of
Whatman #1 filter paper and concentrated
under vacuum at 70°C to a ﬁnal volume of
approximately 75 mL. Aliquots of this mate-
rial were dried under nitrogen at 70°C and
redissolved in 100% ethanol for further
purification or evaluation for mitogenic
activity. When concentrated to ~75 mL,
2–4 µL of this extract stimulates MCF-7
human breast cancer cell proliferation in a
manner equivalent to the response obtained
with 1 nM estradiol. MDA-MD-231 cells
are more sensitive to CM than MCF-7 cells.
Appropriate control experiments have shown
that CM in our preparations is derived from
corn kernels and/or cob and is not a solvent
contaminant. CM activity is also readily
extracted from ground corncob bedding
with ethyl acetate (ETAC) (not shown). For
the ETAC extractions, approximately 200 g
ground corncob bedding was extracted at
22°C for 24–48 hr in 600 mL of HPLC-
grade ETAC, filtered, and concentrated as
described above for methanol extracts. Either
extraction procedure generated approxi-
mately equivalent quantities of chromato-
graphically indistinguishable CM, although
the ETAC extracts typically contained lower
quantities of polar contaminants.
In one series of experiments, 12 oz
commercially obtained corn tortillas were
extracted with ~400 mL of methanol as
described above for the ground corncob bed-
ding. This tortilla extract was diluted to 20%
methanol with milliQ-water (Millipore,
Austin, TX), loaded onto a C18 mini-col-
umn as described below, washed with 60%
methanol, and eluted with 80% methanol.
An aliquot of the 80% methanol extract (100
µL) was taken to dryness under nitrogen at
70°C and redissolved in 2 mL ethanol.
Aliquots (2–10 µL) of this partially puriﬁed
preparation were added to MCF-7 breast
cancer cells to assess effects on cellular prolif-
eration as described below. 
Chromatography of CM on C18 reverse-
phase mini-columns. The mitogenic agent
in CM preparations is quantitatively recov-
ered from Spice C18 reverse-phase car-
tridges, BOND ELUTE C18 mini-columns
(Rainin/Varian, Walnut Creek, CA), or
Sep-Pak C18 reverse-phase cartridges
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containing < 35% methanol or ethanol. To
further explore the use of C18 reverse-phase
resin for CM puriﬁcation, we diluted aliquots
of the corncob bedding methanol extract (CM)
with HPLC-grade water to a ﬁnal methanol
concentration of approximately 10% and
loaded them onto BOND ELUTE mini-
columns (500 mg resin). The pass-through and
column wash with 10% methanol were sepa-
rately collected, as were the sequential eluates
with 10 mL volumes of 20%, 40%, 60%,
80%, and 100% methanol. Each eluate was
taken to dryness under nitrogen at 70°C and
redissolved in 2.0 mL of 100% ethanol before
addition to the cell cultures. Elution of the
mini-columns with 80% methanol (or
ethanol) resulted in complete recovery of the
mitogenic activity from corncob bedding or
from fresh corn kernels and cob. As antici-
pated, we subsequently demonstrated that the
elution behavior of the mitogenic activity from
C18 mini-columns and cartridges with
20–100% ethanol mirrored that observed with
methanol. This simpliﬁed the exchange of sol-
vents used for extraction (methanol) to those
more suitable for addition to cell cultures
(100% ethanol) or [3H]estradiol binding
assays. The purified material was simply
diluted to < 35% methanol with milli-Q water,
collected on C18 mini-columns equilibrated in
milli-Q water, washed with 35% ethanol in
milli-Q water, and collected with 100%
ethanol. The ethanol eluate of the mitogenic
agent could be directly added to cultured cells.
Reverse-phase HPLC of CM in ground
corncob extracts. The data generated on the
C18 cartridges and mini-columns suggested
that chromatography on C18 reverse-phase
HPLC columns may be used to further purify
CM from these various corn extracts. HPLC
was performed on a Beckman Gradient
Liquid Chromatography System (Beckman
Instruments, Fullerton, CA) equipped with
single-channel ﬁxed wavelength detector (280
nm). Partially purified CM preparations
(80% methanol fraction eluted from the C18
mini-columns) were injected onto a Waters
µBondapak C18 analytic HPLC column
eluted isocratically with water:methanol
(30:70) at a ﬂow rate of 1 mL/min. Fractions
were collected and assayed for mitogenic
activity in MCF-7 cell cultures on 24-well
plates as described below. The mitogenic
activity coeluted with a single peak of UV-
absorbing material, suggesting that these
preparations were relatively clean and fairly
homogeneous with respect to the mitogenic
activity. 
Assessment of mitogenic activity of CM
preparations in human breast cancer cells.
We assessed the effects of the various CM
preparations and chromatography fractions
on the proliferation of human breast
(MCF-7 or MDA-MD-231) cells by routine
procedures in our laboratory (12,19,20). For
these studies, the CM preparations and col-
umn fractions were dried under nitrogen at
60–70°C and redissolved in a known volume
(100–500 µL) of 100% ethanol or collected
from C18 mini-columns in 100% ethanol as
described above. Aliquots (1–10 µL) of each
sample or equivalent quantities of 100%
ethanol (controls) were added to quadrupli-
cate wells (24-well plates seeded with 30,000
cells/well) of MCF-7 or MDA-MD-231 cells
grown in 1 mL phenol red-free medium con-
taining 10% charcoal-stripped, sulfatase-
treated, fetal calf serum (21). We added
estradiol (1 nM) and ICI-182,780 (ICI; 10
nM) to the wells in 1–10 µL ethanol where
indicated. We determined cell numbers
(hemocytometer counts) 4–6 days after treat-
ment (22,23). In some experiments, expo-
nentially growing MCF-7 cells were treated
with 1 nM estradiol (E2), 10 nM ICI-
182,780, and/or 10 µL highly purified
ground corncob bedding extract (80% eluate
from Spice C18 Cartridge), and we deter-
mined the cell number 6 days after treat-
ment. We calculated the results from
quadruplicate wells for each treatment group
as a percent of control (cells grown in the
presence of ethanol vehicle), and plotted the
data as the mean ± SE to assess treatment
effects on cellular proliferation. Data were
analyzed statistically via ANOVA and a suit-
able multiple range test on the treatment
means using Instat as described below.
Interaction of CM with ER and type II
sites in rat uterine cytosol and nuclear
preparations. We evaluated the ability of
CM to competitively inhibit [3H]estradiol
binding to ER or nuclear type II sites
(14,24). It is difﬁcult to cleanly discriminate
between [3H]estradiol binding to ER and
type II sites, even with full saturation analy-
sis over a wide range of [3H]estradiol con-
centrations. Therefore, we used assay
procedures that separately measure either ER
or type II sites with single saturating
[3H]estradiol concentrations (10 nM or ER
and 30 nM for type II sites) as previously
described in detail (24). For competition
studies with ER, uteri from adult ovariec-
tomized rats were homogenized in TED
buffer (10 mM Tris, 1.5 mM EDTA,
10 mM dithiothreitol, pH 7.4; this reducing
agent blocks type II binding sites) and
aliquots of the high-speed (39,000 g ×
30 min) supernatant (cytosol) were incu-
bated (30°C for 30 min) in the presence of
10 nM [3H]estradiol ± various aliquots of
crude or HPLC purified CM (or 300-fold
excess diethylstilbestrol) under conditions
that measure ER. Following incubation,
bound and free steroid was separated by
hydroxyapetite adsorption as previously
described (14). Type II sites do not bind
[3H]estradiol in the presence of dithiothre-
itol, and ER is quantified without interfer-
ence from this secondary binding component
(23). We did not discriminate between CM
binding to ERα or ERβ (25,26) in these
cytosol preparations. 
CM competition for nuclear type II sites
was performed with uterine nuclear fractions
from estradiol-implanted rats because nuclear
type II sites are stimulated 30-fold in the
ovariectomized rat uterus by estradiol (14).
Uterine nuclear suspensions prepared from
estradiol-implanted rats were incubated in
the presence of 30 nM [3H]estradiol ± vari-
ous aliquots of crude or HPLC-puriﬁed CM
(or 300-fold excess luteolin) under condi-
tions (4°C for 60 min) that do not measure
occupied ER (24). Thus, type II sites can be
measured with a single saturating [3H]estra-
diol concentration without interference from
ER. Results from these binding studies are
expressed as percent [3H]estradiol bound,
where 100% (control) represents approxi-
mately 10,000 cpm for ER and 25,000 cpm
per assay tube for type II sites.
CM effects on human prostatic cancer
cells in vitro and in vivo. We used PC-3
prostate cancer cells (ATCC) to assess CM
effects on the growth and proliferation of
prostate cancer cells in vitro and in vivo. The
cells were maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM)-F12 containing
10% fetal calf serum and 1% penicillin-strep-
tomycin as described previously by our labora-
tory (11,23,27). To assess CM effects on cell
proliferation, PC-3 cells were seeded in 96-
well plates (1,000 cells/well) containing
200 µL DMEM-F12 medium and allowed to
attach for 24 hr. After attachment (day 0), the
medium was replaced with fresh medium, and
the cells were treated with 1–10 µL of ethanol
(controls) or CM (80% methanol C18 frac-
tion) reconstituted in ethanol. The cells were
grown in the presence of CM for 6 days and
medium, and the CM or vehicle was replaced
every 48 hr. We determined cell number by
hemocytometer counts or via the MTT assay
(28). The methyl thiazoyl tetrazolium (MTT)
assay routinely duplicates results determined
on the basis of DNA content per well or
hemocytometer counts (not shown). Cellular
proliferation can be readily quantiﬁed with the
MTT assay procedure in 96-well plates with a
microplate reader at 570 nm.
We also assessed the growth rate of sub-
cutaneous PC-3 cell xenografts in Harlan
adult male BALb/c nu/nu athymic nude
mice (6–10 mice per group) housed on pure
cellulose or ground corncob bedding. After
housing on the appropriate bedding mater-
ial for 21 days, these mice were injected
subcutaneously in the ﬂank with PC-3 cells
(3.5 × 106 cells in 0.15 mL DMEM-F12
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Approximately 3 weeks after PC-3 cell injec-
tion, subcutaneous solid tumors ~0.3 cm ×
0.3 cm (length × width) were detected in
> 99% of the animals. This was designated
day zero, and tumor size (length × width)
was monitored for the next 8 days. Results
were expressed as the percent day 0 control
throughout the course of the study. These
tumors grew rapidly, and the animals were
sacrificed before the PC-3 cell xenografts
reached 10% of their body weights. 
Statistical analyses. Data, where appro-
priate, were analyzed statistically with Instat
(GraphPad Software) using a one-way
ANOVA and an appropriate multiple range
test on the treatment means. Values in cell
proliferation assays represent the means ±
the SE for 12–16 independent observations
(three replicates of assays using quadriplicate
wells per treatment group). Uterine weights
values typically represent data collected from
8–10 animals per treatment group (for 2–3
replicate experiments) and tumor growth
values were generated from tumors growing
in 6–10 mice per treatment group. 
Results
Effects of bedding on uterotropic response,
reproductive behavior, and ovarian cyclicity.
The search for CM was prompted by the fact
that the breeding efﬁciency of our rats housed
on ground corncob bedding was substantially
reduced compared to that of rats housed on
woodchips. This suggested that the corncob
bedding contained an endocrine-disrupting
agent that was not present in the hardwood
chips or perhaps other bedding materials. To
evaluate these possibilities, we assessed the
effects of housing conditions on uterotropic
response (uterine weight and DNA content)
in the rat. This is a classic bioassay for estro-
genic activity and/or antiestrogenic activity
(29). When adult, ovariectomized rats were
housed on woodchips (Figure 1), uterine wet
weight (p < 0.01) and DNA content doubled
(p < 0.01) relative to those of controls (adult-
ovariectomized rats housed in wire cages).
This appeared to be a classic estrogenic
response, which reversed when the animals
housed on the woodchips were returned to
wire cages (data not shown). Thus, it appears
that the woodchips contained an estrogenic
component that reversibly modulated uterine
growth, and we used this response for com-
parison to responses obtained in animals
housed on the corncob bedding. This is not
surprising in view of the fact that woodchips
are likely to contain phytoestrogens known
to stimulate uterotropic response in the rat
(2,30,31).
Conversely, housing intact adult female
rats on ground corncob bedding decreased (p
< 0.01 or p < 0.001) uterine wet weight
(Figure 2A) and DNA content (Figure 2B)
relative to wire-housed controls or in animals
housed on the woodchips (Figure 1).
Approximately 90% of the animals housed in
wire cages for 2 weeks or 5 weeks displayed
normal estrous cycles. Marked reductions
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Figure 3. Effects of housing conditions on the estrous cycle in adult Sprague-Dawley rats. Sixty-day-old
female rats (8–10 per group) were housed in wire cages or on corncob bedding for either 2 or 5 weeks,
and daily estrous cycles were recorded (A). A second group of 10 rats (B) were housed in wire cages for
14 days, moved to corncob bedding for 14 days, and returned to wire cages for 14 days. Daily vaginal
smears were collected throughout this period. Exposure to the corncob bedding disrupted estrous cycles
and caused persistent metestrus in adult female rats, and this effect was reversible when the animals
were returned to the wire cages.
Figure 2. Effects of housing on corncob bedding on wet weight and DNA content of the rat uterus. Adult
intact or ovariectomized (Ovex) rats were housed in wire cages or on corncob bedding for 14 days before
uterine wet weight (A) and DNA content (B) were determined. Housing adult, ovariectomized animals on
ground corncob bedding signiﬁcantly reduced (**p < 0.01 or ***p < 0.001) uterine wet weight (A) or DNA
content (B) compared to intact animals housed on wire.
Figure 1. Effects of housing conditions on wet
weight and DNA content of the rat uterus. Adult,
ovariectomized rats were housed in wire cages or
on woodchips. Uterine wet weight (µg/uterus) and
DNA content (µg/uterus) were higher (**p < 0.01) in
animals housed on woodchips than in wire cages.
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5 weeks(50–80%) in cyclicity were noted in animals
housed on corncob bedding (Figure 3A). The
vaginal smears from these animals reﬂected a
state of persistent metestrus (15), and the
acyclicity was associated with a substantial
decrease (> 90%) in lordosis response (Figure
4A). Normal cyclicity (Figure 3B) and lordo-
sis response (data not shown) resumed when
these animals were returned to wire housing.
That the effects of the bedding extract on
uterine wet weight and DNA content were
observed in intact but not in ovariectomized
animals (Figure 2) suggests that an ovarian
component may be involved in this response.
Such an effect could involve the modulation
of gonadotrophin release by factors derived
from corncob bedding and downstream
effects on ovarian steroid biosynthesis.
Similarly, males housed on ground corncob
bedding also displayed substantial reductions
(Figure 4B) in mounting behavior (> 98%),
intromission (> 97%), ejaculation (> 98%),
ejaculation latency (> 79%), and grooming
frequency (~75%) when placed with breeder
females, which could be linked to the hypo-
thalamic–pituitary–testicular axis. 
Effects of corncob extracts on breast
cancer cell proliferation. Because exposure
to ground corncob bedding induced persis-
tent metestrus in rats, we suspected that an
agent derived from the corncob bedding was
modulating estrogen-regulated pathways.
Therefore, we used the MCF-7 human
breast cancer cell line to monitor extracts of
ground cob bedding (CM) for estrogenic or
antiestrogenic activity. MCF-7 human breast
cancer cells contain ER and proliferate in
response to estrogen. However, this prolifer-
ative response is ablated by antiestrogens
such as ICI-182,780 (32). Conversely,
MDA-MD 231 cells lack functional ER and
do not respond to estrogens and antiestro-
gens in a classical manner. These cells were
used as ER-negative controls (32–35). The
active agent (CM) was extracted from ground
corncob bedding at 70°C with methanol,
dried under vacuum, and reconstituted in
100% ethanol. This CM preparation was
added to exponentially growing cultures of
MCF-7 or MDA-MD-231 cells, and equiva-
lent quantities of 100% ethanol were added
to appropriate controls. Treatment of the
cells with various quantities (2–10 µL) of the
nondiluted extract produced a classic
dose–response curve in MCF-7 cells. Lower
doses of the extract stimulated MCF-7 cell
proliferation, and the magnitude of the stim-
ulatory response was equivalent to that
obtained with 1 nM estradiol (Figure 5A).
MCF-7 cell proliferation was inhibited (p <
0.01) by higher doses of the extract, and this
response may have been augmented by
coincidental treatment with estradiol.
Whether this inhibitory response resulted
from an additive or synergistic interaction to
CM and estradiol remains to be resolved.
Surprisingly, the lower concentrations of the
corncob bedding extract failed to stimulate
MDA-MD-231 cell proliferation (Figure
5A), as was the case for MCF-7 cells. Higher
doses of the CM extract, however, inhibited
(p < 0.01) MDA-MD-231 cell proliferation
(Figure 5A), and this response was also
enhanced by estradiol treatment. Because
MDA-MD-231 cells lack functional ER, the
inhibitory interaction between estradiol and
CM likely results from toxicity.
Partial puriﬁcation and characterization
of CM from ground corncob. Fractionation
and purification of the corncob extract on
Spice C18 cartridges demonstrated that the
mitogenic activity detected in MCF-7 cell
cultures eluted from the cartridge in the
80% methanol fraction (Figure 5B). Lower
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Figure 4. Effects of housing on mating behavior in male and female rats. Ejac. latencies, ejaculation
latencies. (A) Adult, ovariectomized rats housed in wire cages (controls) or on ground corncob bedding
(corncob) were primed with estrogen plus progesterone, and their sexual behavior (lordosis response)
in the presence of proven male rats was scored and quantitated. (B) The sexual performance of adult
male proven breeders housed on Sani-chip (control) or ground corncob bedding (corncob) in the pres-
ence of sexually receptive ovariectomized rats was evaluated. The numbers of mounts, intromissions,
ejaculations, ejaculation latencies in seconds, and grooming frequencies in a 30-min test period with
each sexually receptive female were scored.
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Figure 5. Effects of a corncob bedding extract (EXT) on the proliferation of human breast cancer cells. (A)
Aliquots (0–10 µL) of CM extract were added to exponentially growing cultures of MCF-7 or MDA-MD-231
cells in the presence or absence of 10 nM estradiol for 6 days. (B) The CM extract was fractionated on a
Spice C18 reverse-phase cartridge by elution with increasing concentrations (20–100%) of ethanol and
aliquots of the fractions were added to the exponentially growing MCF-7 or MDA-MD-231 cells.
Treatment effects on cell number were determined 6 days after treatment.
*p < 0.05.
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econcentrations of methanol (20–60%) failed
to elute the mitogenic agent. The stimulatory
response obtained with the 80% methanol
fraction was similar to that obtained with an
equivalently diluted preparation of the crude
extract, suggesting that recovery was quantita-
tive. Surprisingly, both the crude (data not
shown) and puriﬁed fractions (80% methanol
eluate) failed to compete for [3H]estradiol
binding to the ER in rat uterine cytosol
(Figure 6A) or in uterine nuclear (data not
shown) preparations. The crude or purified
extract also failed to significantly modulate
ER-mediated gene transcription in HeLa cells
transfected with the estrogen-receptor
(psvmt:wER) and reporter gene (data not
shown) containing an estrogen responsive ele-
ment (ERE; pERE-ELb-LUC) (36,37).
Similarly, treatment with the antiestrogen
ICI-182,780 failed to inhibit the stimulation
of MCF-7 cell proliferation by the partially
puriﬁed corncob bedding extract (Figure 6B).
Under these conditions, this level of antiestro-
gen reduced the proliferative response of these
cells to estradiol by nearly 70%. Thus,
although MCF-7, but not MDA-MD-231,
cells were stimulated by this mitogen in the
corncob bedding extract, it is unlikely that the
ER is directly involved in this response.
Similarly, although this partially puriﬁed CM
competitively inhibited [3H]estradiol binding
to nuclear type II sites in rat uterine prepara-
tions (Figure 6A), more highly puriﬁed prepa-
rations were devoid of this activity. Thus,
although plant-derived bioflavonoids, their
metabolites, and/or analogs may control cellu-
lar proliferation via interaction with nuclear
type II sites, apparently the CM does not
directly regulate breast cancer cell proliferation
through this mechanism (11,12). Obviously,
downstream effects from either ER or type II
binding site interactions cannot be ruled out.
On the basis of the findings with estra-
diol and ICI-182,780 noted in Figure 6, we
reasoned that MDA-MD-231 cells might
have failed to proliferate in response to CM
(Figure 5A) because these cells are more sen-
sitive to this agent(s). If so, the quantities of
CM extract used in the experiments
described in Figure 5A might have been at
the higher end of the MDA-MD-231 cell
dose–response curve where cell growth inhi-
bition would have been expected. This possi-
bility was evaluated in the studies described
in Figure 7. When the corn bedding extract
was diluted 1- to 1,000-fold before addition
to MDA-MD-231 cells, a classic biphasic
dose–response curve was obtained. These
lower concentrations of the diluted CM
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Figure 6. Interaction of corn mitogen extract (EXT) effects with ER and nuclear type II sites in rat uterus
and with estrogenic response in MCF-7 human breast cancer cells. (A) Aliquots of the 80% methanol
Spice cartridge eluate of CM were diluted (1–50 µL) in ethanol-TE buffer vehicle (control) and added to
the cytosol (ER) or nuclear preparations (type II sites) from rat uterus, and [3H]estradiol binding to ER or
type II sites was determined. (B) The effects of a pure antiestrogen (ICI-182,780) on the stimulation of
MCF-7 cell proliferation by CM preparations were also evaluated.
***p < 0.001.
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Figure 7. Effects of diluted CM preparations on
the MDA-MD-231 cell proliferation. The 80%
methanol C18 CM fraction described in Figure 5
was diluted 2- to 1,000-fold in ethanol and 5 µL
aliquots of these diluted preparations or 5 µL of
100% glass-distilled ethanol (control) were added
to exponentially growing cultures of MDA-MD-
231 cells. Cell number was determined 6 days
after treatment.
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Figure 8. Effects of HPLC-puriﬁed CM preparations on MCF-7 human breast cancer cell proliferation and
interactions with ER and nuclear type II [3H]estradiol binding sites. An aliquot of the 80% methanol frac-
tion of the CM from a C18 mini-column was injected onto a Waters µBondapak C18 reverse-phase col-
umn. (A) Aliquots of fractions (1 min) were reconstituted in 100% ethanol and added to exponentially
growing MCF-7 cells for assessment of effects on cellular proliferation. (B) Unlike the partially purified
preparations of CM (Figure 6A), the HPLC peak fraction failed to compete for [3H]estradiol binding to ER or
nuclear type II [3H]estradiol binding sites.
***p < 0.001. 
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Type II (HPLC)extract stimulated cellular proliferation
(p < 0.01) relative to controls, whereas the
higher concentrations (Figure 5A) were
inhibitory. Thus, even in rapidly proliferating
ER-independent MDA-MD-231 cell pop-
ulations, CM can stimulate proliferation. 
Reverse-phase HPLC of CM prepara-
tions. Injection of the fractionated corncob
bedding extract (80% methanol eluate from
Spice cartridge) onto a Waters µBondapack
C18 reverse-phase column (Figure 8A)
demonstrated that the mitogenic activity (in
MCF-7 cells) eluted with a single major peak
of UV-absorbing material. Thus the 80%
methanol eluate from the Spice cartridge
chromatographed as a single major compo-
nent on HPLC under these experimental
conditions. Aliquots of this puriﬁed material
in the HPLC peak fractions failed to
compete for [3H]estradiol binding to ER or
nuclear type II sites (Figure 8B), further rul-
ing out direct modulation of estrogen-
dependent pathways by this mitogenic
agent. Thus, HPLC purification removed
the component capable of competing for
type II sites in the crude CM preparations.
Inhibition of ovarian cyclicity by CM
preparations. The HPLC analysis revealed
that the CM preparations (80% methanol elu-
ate from C18 mini-columns) were suitable for
assessment of biologic activity in animal stud-
ies. For these experiments, three groups of 10
ovariectomized rats each (controls, low-dose
extract, and high-dose extract) were housed in
wire cages for 6 weeks, and daily vaginal
smears were collected to confirm normal
estrous cycles. The animals were then given
vehicle (controls), or low- (0.2 mL per 400
mL vehicle) or high-dose (2.0 mL per 400 mL
vehicle) of CM (80% methanol eluate from
Spice cartridge reconstituted in ethanol) in the
drinking water for the next 14 days, and daily
vaginal smears were collected. Within 7 days
after treatment, 75% of the rats receiving the
low dose and 100% of the animals receiving
the high dose of bedding extract displayed per-
sistent metestrus smears. By the second week
of treatment, 100% of the animals in either
group were acyclic (Figure 9). Thus, treatment
with the puriﬁed bedding extract caused per-
sistent metestrus in these animals, which mim-
icked the results obtained when the female rats
were housed on this material (Figure 3). These
findings suggest that the mitogenic activity
puriﬁed from corncob bedding extracts (CM)
is likely to be responsible for the disruption of
reproductive behavior and function observed
in our initial bedding studies.
Extracts from fresh corn kernels or cob
also contained this mitogenic activity when
assayed in MCF-7 cells (Figure 10A) and the
mitogen fractionated on Spice C18 cartridges
in a manner indistinguishable (Figure 10B)
from that isolated from ground corncob bed-
ding (Figure 5B). A similar mitogenic activity
in a corn tortilla extract preparation (80%
methanol eluate from C18 mini-columns)
was detected after addition to cultured MCF-
7 cells (Figure 11), demonstrating that
human food products derived from corn con-
tain this mitogenic material. We suspect that
corn oil also contains this substance(s) but
this has not been investigated.
Effects of bedding material on the prolif-
eration of PC-3 cell human prostatic cancer
cells in vitro and in athymic nude mice. CM
preparations stimulate the proliferation of
estrogen-dependent (MCF-7 cells) and estro-
gen-independent (MDA-MD-231 cells)
human breast cancer cells, suggesting that ER
is not involved in the response. Therefore, this
mitogenic agent may also stimulate the prolif-
eration of androgen-independent PC-3 human
prostatic cancer cells in vitro and in vivo, as
well. We routinely grow PC-3 cells in our labo-
ratory and have used athymic nude mice as
hosts for subcutaneous PC-3 cell xenografts to
investigate treatment effects on PC-3 cell
xenografts in vivo (20). Therefore, we used this
model to evaluate CM effects on prostatic can-
cer cell proliferation. These experiments clearly
demonstrate that cultured PC-3 cells respond
in a dose-dependent manner to the CM prepa-
rations, and a typical bell-shaped curve was
Articles • An endocrine disruptor in corncob bedding
Environmental Health Perspectives • VOLUME 110 | NUMBER 2 | February 2002 175
150
125
100
75
50
25
0
N
o
r
m
a
l
 
e
s
t
r
o
u
s
 
c
y
c
l
e
s
 
(
%
)
1–6
Weeks
Control
Low dose
High dose
789
Start treatment
Figure 9. Effects of CM preparations on estrous
cycles in adult female rats. Adult female rats
housed in wire cages displayed normal 4- to 5-
day cycles (weeks 1–6). At the beginning of week
7, the animals (10 per group) were given 2%
Tween-80-Tap water vehicle (controls) or a low
(50 µL/400 mL) or high (100 µL/400 mL) dose of the
purified CM extract (80% methanol Spice car-
tridge eluate). Vaginal smears were collected
daily during weeks 7–9. 
185
165
145
125
105
85
65
C
e
l
l
/
w
e
l
l
 
(
%
 
c
o
n
t
r
o
l
)
A B Cells/well
C
o
n
t
r
o
l
C
e
l
l
 
n
u
m
b
e
r
 
(
%
 
c
o
n
t
r
o
l
)
350
300
250
200
150
100
50
0
***
***
***
**
*
2
 
µ
L
 
K
e
r
n
5
 
µ
L
 
K
e
r
n
1
0
 
µ
L
 
K
e
r
n
2
 
µ
L
 
C
o
b
5
 
µ
L
 
C
o
b
1
0
 
µ
L
 
C
o
b
02 04 0 6 08 0100
C18 Cartridge fraction (%)
C18 Cartridge fraction
Fresh corn
Cob bedding
Figure 10. Characterization of mitogenic activity in extracts of fresh corn. (A) Methanol extracts from
fresh corn kernels (Kern) or cob purchased in a local supermarket were added to exponentially growing
MCF-7 cells and cell number was determined 6 days following treatment. (B) Fractionation of the extract
from the corn kernels on Spice C18 cartridges demonstrated that the mitogenic activity eluted with 80%
methanol in a manner indistinguishable from that of the ground corncob bedding extract.
*p < 0.05. **p < 0.01. ***p < 0.001. 
Figure 11. Effects of corn tortilla extracts on the
proliferation on MCF-7 human breast cancer cell
proliferation. MCF-7 cells were treated with vari-
ous concentrations (1–10 µL) of partially purified
(80% methanol fraction from C18 mini-column
reconstituted in 500 µL of ethanol) corn tortilla
extract or ethanol (controls) for 6 days. Cell prolif-
eration was estimated on the basis of the MTT
assay.
250
200
150
100
50
M
T
T
 
a
b
s
o
r
b
a
n
c
e
 
u
n
i
t
s
 
(
%
 
c
o
n
t
r
o
l
)
Control
Treatment
MTT absorbance
2 µL (Extract) 5 µL (Extract) 10 µL (Extract)obtained (Figure 12A). This ﬁnding mirrored
results obtained with MCF-7 and MDA-MD-
231 cells mentioned above. Furthermore,
PC-3 cell xenografts grew more rapidly in
nude mice housed on corncob bedding com-
pared to animals housed on pure cellulose
(Figure 12B). Thus, the mice apparently
adsorbed and/or consumed a component
(CM) from corncob bedding that is mitogenic
to the PC-3 cell xenografts, enhancing the
growth of these xenografts. We believe this
factor is CM because preparations of this
mitogen directly stimulated PC-3 cells in vitro
as well. We anticipate that similar results
would be obtained with MCF-7 and/or
MDA-231 cells in this model system, and this
will be evaluated in the future.
Discussion
The studies presented here describe a novel
endocrine-disrupting agent purified from
ground corncob bedding and fresh corn or tor-
tillas which likely has mitogenic activity in
breast and prostatic cancer cells in vitro
(Figures 5–8, 10–12) and in vivo (Figure 12B).
We have developed methodology for purifying
this mitogenic activity (CM) and the elucida-
tion of the chemical structure of this substance
is a major priority of this laboratory. Our pre-
sent experiments strongly suggest that CM is
not a phytoestrogen (37–39), bioﬂavonoid, or
phenolic cell growth regulatory agent such as
genistein, luteolin, or methyl-p-hydrox-
yphenyllactate, respectively (20,40). This
notion is based on its solubility properties and
chromatographic behavior on HPLC. Under
the conditions employed in this study, free
steroids, bioﬂavonoids, nonsubstituted fatty
acids, and other relatively nonpolar com-
pounds are unlikely to elute. Similarly, the
antagonistic effect of CM on uterine growth
and estrous cyclicity and particularly on the
inability of these preparations to compete for
[3H]estradiol binding to ER or nuclear type II
sites (Figures 6A and 8B) would suggest that
this compound(s) is not free steroid, phenol,
bioﬂavonoid, or bioﬂavonoid metabolite. It is
well documented that phytoestrogens,
bioﬂavonoids, and phenolic metabolites inter-
act with ER and/or nuclear type II [3H]estra-
diol binding sites (41). Similarly, CM
preparations also failed to activate ER-medi-
ated gene transcription in HeLa cells trans-
fected with ER (psvmt:wER) and reporter gene
(data not shown) containing an ERE pERE-
ELb-LUC, further supporting the concept that
CM is regulating cellular proliferation via non-
ER-dependent pathways. However, validating
these concepts requires further work, particu-
larly in light of recent studies demonstrating
that estrogenic induction of mitogen-activated
tyrosine protein kinase pathways can occur
independent of the ER (42,43). Thus, induc-
tion of these pathways may be at least partly
responsible for the response of MCF-7 and
MDA-MD-231 breast cancer cells, LNCaP
prostate cancer cells, and the uterus to CM in
our preparations. 
Alternatively, perhaps CM is a progestino-
gen (antiestrogen) because it induces persistent
vaginal metestrus in the rat. It is well known
that human breast cancer cells proliferate in
response to progesterone (44), a response
dependent on the progesterone receptor (PR).
However, aliquots of the crude or highly puri-
ﬁed corncob bedding extract failed to compete
for [3H]progesterone binding to the PR (data
not shown) in rat uterine cytosol preparations
(45). These ﬁndings suggest that CM does not
bind to progesterone receptor in a classic man-
ner, although we certainly cannot rule out the
possibility that the compound activates prog-
esterone receptor in a ligand-independent
manner (17,46). Studies are under way to
examine this possibility.
Regardless of its mechanism of action, the
present in vitro and in vivo studies demonstrate
that the corncob bedding-derived factor (CM)
is an active mitogen in ER-positive and ER-
negative breast cancer cells and androgen-inde-
pendent PC-3 human prostatic cancer cells.
Housing rats on ground corncob bedding dis-
rupts male (Figure 4B) and female mating
behavior (Figure 4A) and estrous cyclicity
(Figures 2 and 3) and stimulates the growth of
human prostatic cancer cell xenografts in
athymic nude mice (Figure 12). Oral adminis-
tration of highly puriﬁed preparations of the
mitogenic agent (CM) to female rats in the
drinking water completely disrupted ovarian
cyclicity in a dose-dependent manner (Figure
9), and preliminary studies have conﬁrmed a
60% reduction in mating behavior in male rats
orally dosed with this CM preparation (data
not shown). Thus, it appears that the mito-
genic activity characterized in corncob extracts
is responsible for the endocrine-disrupting
characteristics of the ground corncob bedding.
This will be evaluated directly after the chemi-
cal identity of the CM is determined.
Aside from its endocrine-disrupting prop-
erties, an agent such as CM must be consid-
ered when designing male or female animal
reproductive studies. At present, we have not
yet identiﬁed species other than rats that may
be affected by exposure to the corncob bed-
ding material. Rats in our animal facility nei-
ther breed nor exhibit reproductive behavior
when housed on corncob bedding. In addi-
tion, because CM will stimulate mammary
and prostatic cancer cell proliferation, it is
likely that these unknown agents will affect
baseline determinations in reproductive stud-
ies in rats and perhaps other species. Perhaps
CM will affect mammary and prostate mor-
phology as well. It is clear from our studies
with nude mice that exposure to the corncob
bedding material accelerates the growth of PC-
3 cell xenografts (Figure 12) in these animals.
Thus mice are able to adsorb an agent from
ground corncob bedding that is indistinguish-
able from CM at this point. Such agents will
obviously affect experimental results in ani-
mals housed on this type of bedding material.
We have detected CM activity in ground
corncob bedding from a number of manufac-
turers by cell proliferation assays and on
HPLC, and this agent(s) is not destroyed by
autoclaving. Thus, housing animals on ground
corncob bedding, regardless of manufacturer,
is likely to inﬂuence experimental results in a
variety of endocrine-controlled systems. Since
ER is not required for response to CM, this
compound(s) could be a general mitogen
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Figure 12. Effects of CM preparations on the proliferation of PC-3 human prostatic cancer cells grown in
tissue culture and as xenografts in athymic nude mice. (A) Exponentially growing PC-3 cells were treated
with the indicated quantities of CM (80% methanol fraction for C18 cartridges). Cell number was deter-
mined by the MTT assay 6 days after treatment. (B) The effects of housing conditions (pure cellulose or
corncob bedding) on the growth of subcutaneous PC-3 human prostatic cancer cell xenografts in athymic
nude mice (6–10 mice per group). Tumor size (length × width) was monitored throughout the study and
expressed as a percentage of the day 0 control value.
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ated in the future.
In summary, although the potential
effects of CM on human populations
remains to be resolved, the studies described
in this article show that in addition to
ground corncob bedding, fresh corn on the
cob (kernels and cob) and corn tortillas con-
tain CM. The CM activity from these foods
stimulates breast and prostatic cancer cellular
proliferation and will likely disrupt endocrine
function and behavior as well. CM does not
bind to the ER or activate ER-dependent
gene transcription in HeLa cells transfected
with ER and ERE-luciferase reporter gene
constructs (data not shown), and its effects
on MCF-7 human breast cancer cell prolifer-
ation are not blocked by a pure antiestrogen
(ICI-182,780). Thus, CM can stimulate
estrogen-dependent and estrogen-indepen-
dent breast and prostatic cancer cell prolifera-
tion at very low doses. These results suggest
that CM may be able to stimulate the prolif-
eration of a wide variety of normal and
abnormal cells in reproductive tissues and
perhaps nonreproductive tissues as well.
Determination of the mechanism of action of
CM and its metabolic fate in laboratory ani-
mals and man is crucial for estimating its
impact on human health and development
and identifying other natural sources for this
type of environmentally derived endocrine-
disrupting/mitogenic agent. It is well known
that ground or milled corncob is also used for
metal finishing and blast cleaning, for litter
and bedding for pets and small animals (as
shown here), as an absorbent for soaking up
aqueous spills, and as a pesticide carrier for ﬁre
ant and grub control, feed additives, animal
health products, and feed. Academic institu-
tions routinely use ground corncob bedding to
house experimental animals used in scientiﬁc
research. Thus, CM present in corn products
may complicate experimental results in animal
studies, and human exposure to this
endocrine-disrupting agent is likely. Although
it is well established that consumption of high-
fat diets (23–24% corn oil) increases the inci-
dence, growth, and metastases of mammary,
liver, and colon cancer in a variety of experi-
mental systems (47–49), the question of
whether acute or sustained exposure to CM
and/or related compounds, alone or in combi-
nation, represents a signiﬁcant health problem
remains to be resolved.
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